Cases 41 - 48 of 48
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01043
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
TEVA PHARMACEUTICALS DEVELOPMENT, INC., v. AMICUS THERAPEUTICS U.S., INC.
as 2:2021cv03105
Plaintiff:
TEVA PHARMACEUTICALS DEVELOPMENT, INC., and TEVA PHARMACEUTICALS, INC.
Defendant:
AMICUS THERAPEUTICS U.S., INC. and AMICUS THERAPEUTICS U.S., LLC
Cause Of Action: 28 U.S.C. § 1331
O'CALLAGHAN v. AUROBINDO PHARMA, LTD. et al
as 1:2020cv15125
Defendant:
TEVAPHARMACEUTICALS USA, INC, AUROBINDOPHARMA USA, INC., TEVA PHARMACEUTICALS INC. and others
Plaintiff:
ROSANNE O'CALLAGHAN
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
BERGEN COUNTY v. PURDUE PHARMA L.P. et al
as 2:2018cv08845
Plaintiff:
BERGEN COUNTY
Defendant:
PURDUE PHARMA L.P., DR. RICHARD SACKLER, ESTATE OF MORTIMER SACKLER and others
Cause Of Action: 18 U.S.C. § 1961
STATE OF ARKANSAS et al v. AUROBINDO PHARMA USA, INC. et al
as 2:2017cv03769
Plaintiff:
STATE OF ARKANSAS , DISTRICT OF COLUMBIA , STATE OF MISSOURI and others
Defendant:
AUROBINDO PHARMA USA, INC., CITRON PHARMA, LLC, HERITAGE PHARMACEUTICALS, INC. and others
Cause Of Action: 15 U.S.C. § 1
Plaintiff v. Defendant
as 2:2017cv04873
Plaintiff:
Plaintiff v. Defendant
Defendant:
Plaintiff v. Defendant
Cause Of Action: 28 U.S.C. § 1441
Plaintiff v. Defendant
as 13-4158
Plaintiff - Appellant:
Plaintiff v. Defendant
Defendant - Appellee:
Plaintiff v. Defendant
Plaintiff v. Defendant
as 2:2012cv02226
Plaintiff:
Plaintiff v. Defendant
Defendant:
Plaintiff v. Defendant
Cause Of Action: 42 U.S.C. § 1983
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
